AndreaBozzo/ceres-open-data-index huggingface dataset:
2010-2011 NSDUH Guide to State Tables and Summary of Small Area Estimation Methodology

This report presents the methodology for calculating State estimates for measures of substance use and mental health based on the combined 2009 and 2010 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE).
Patent AT-E401335-T1: [Translated] REDUCING THE QUANTITY OF HALOGENIDES IN DIHYDROCARBYL MIXTURES

This invention provides a process for reducing the amount of soluble halide in a solution comprising a liquid organic medium, at least one viscosity reducing agent, at least one dihydrocarbylmagnesium compound, and an initial amount of soluble halide. The process comprises mixing at least one alkali metal with the solution at a mole ratio of alkali metal to magnesium of less than about 1:2.5, thereby forming precipitated soluble halides. Also provided by this invention is a process for reducing the amount of soluble halide in a slurry comprising a liquid organic medium, at least one viscosity reducing agent, at least one dihydrocarbylmagnesium compound, solids from the formation of said dihydrocarbylmagnesium compound, and an initial amount of soluble halide. This process comprises mixing at least one alkali metal with the slurry at a mole ratio of alkali metal to magnesium of less than about 1:1.25, thereby forming precipitated soluble halides.
Patent AT-E401722-T1: [Translated] METHOD AND ARRANGEMENT FOR TRANSMITTING INFORMATION IN A PACKET RADIO SERVICE

The invention relates generally to a method and an arrangement for transferring information in a packet radio service. The invention further concerns the technology of transferring control information relating to packet data transfer resources on individual packet-switched radio connections at the interface between a transmitting device and a receiving device. It s an objective of this invention to provide a method and a system that offers solutions to the prior art problems. Especially, it is an object of this invention to provide a solution for signalling, which enables the u
Protective Factors Part 1

This Child Welfare Information Gateway Podcast is available on Apple Podcasts
  
  

, GooglePlay
  
  

, Spotify
  
  

, Stitcher
  
  

, SoundCloud
  
  

, and the Child Welfare Information Gateway
  
  

 website. Subscribe to receive new episodes as they are released.

Metadata-only record linking to the original dataset. Open original dataset below.
Effects on respiratory function of the head-down position and the
		  complete covering of the face by drapes during insertion of the monitoring
		  catheters in the cardiosurgical patient

Background:
          We evaluated the effect on the respiratory gas exchange of the
				30° head-down position and the complete covering of the face by sterile
				drapes. These are used to cannulate the internal jugular vein and position the
				pulmonary artery catheter in the cardiosurgical patient. During the two
				manoeuvres, 20 coronary patients and 10 patients with end-stage heart disease
				were supplied with oxygen (FiO2 =0.4) by a
				Venturi mask, while 20 coronary patients breathed room air. The arterial blood
				samples to measure oxygen (PaO2) and carbon dioxide
				(PaCO2) tension and oxygen saturation (SaO2) were
				analysed by a blood gas system.
        
        
          Results:
          The contemporary application of the head-down position and the
				drapes over the face significantly increased PaO2 and
				SaO2 in all the patientssupplied with oxygen. Without the head-down
				position, leaving the drapes over the face, did not significantly change the
				two parameters in the coronary patients supplied with oxygen, but induced a
				significant increase in PaO2 and SaO2 in the patients
				with end-stage heart disease. In the coronary patients that were breathing room
				air, PaO2 and SaO2 were stable throughout the study.
        
        
          Conclusions:
          We conclude that the 30° head-down position and the complete
				covering of the face by drapes does not interfere with respiratory gas exchange
				and can be safely performed in coronary patients supplied with oxygen or
				breathing room air and in patients with end-stage heart disease supplied with
				oxygen (FiO2 of 0.4).
Patent AT-E399601-T1: [Translated] ANTIMICROBIAL PACKAGING MATERIALS AND METHOD FOR PRODUCING THE SAME

Zeolite-containing dispersions used to place an anti-microbial coating onto packaging materials are disclosed. The dispersions can be either water or solvent based and include a) a polymer having an acid number of less than about 200, and b) from about 0.5% to about 10% by weight zeolites containing anti-microbial metal ions. The zeolites have a particle size of between about 2 and about 7 microns and a pore size of between about 3 and about 5 Angstroms. The dispersions can be printed onto various packaging materials to render them anti-microbial. After drying onto packaging material, the zeolites release anti-microbial metal ions, such as silver ions, on exposure to moisture.
24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139]

Background
          Early studies with desloratadine demonstrated efficacy in treating seasonal allergic rhinitis (SAR). A dose-ranging study was conducted to characterize its 24-hour efficacy in patients with SAR.
        
        
          Methods
          Patients (N = 1,026) were randomly assigned once-daily (QD) desloratadine (2.5, 5, 7.5, 10, or 20 mg) for 2 weeks in a placebo-controlled, double-blind study. The end point of 24-hour efficacy was assessed by the mean change from baseline in the average AM instantaneous total symptom score (TSS) over the treatment period. Day 2 data were assessed for efficacy of desloratadine following the first dose. Other efficacy variables included AM/PM previous total nasal and nonnasal symptom scores and individual symptom scores.
        
        
          Results
          Desloratadine 5–20 mg was significantly (P < .01) more effective than placebo in improving total AM instantaneous TSS and AM/PM previous total nasal and nonnasal symptom scores. This dosing range also was significantly (P < .01) more effective than placebo for reducing AM instantaneous TSS beginning with the first dose; thus, demonstrating the full 24-hour efficacy of desloratadine. AM/PM previous scores for all individual symptoms, including nasal congestion, were also significantly improved versus placebo (P < .05) with desloratadine at 5, 7.5, and 20 mg. All treatments were well tolerated. There were no clinically meaningful changes in electrocardiogram parameters.
        
        
          Conclusion
          Desloratadine 5–20 mg provided significant 24-hour relief of SAR signs and symptoms. There were no statistically significant differences between the 4 largest doses suggesting that desloratadine 5 mg QD offers the best therapeutic profile for patients with SAR.
Patent AT-E401838-T1: [Translated] EXPANDABLE STENT IN THE SHAPE OF A LADDER

The present invention provides a lumen support stent for use in an artery or any body lumen. The stent is formed from a plurality of ladder elements having elongated ribs and end rungs affixed to the elongated ribs. The elongated ribs of adjacent ladder elements are slidably engaged by the end rungs of adjacent ladder elements. Sliding of the elongated ribs creates a variable distance between the end rungs of adjacent ladder elements. Consequently, the stent has a first diameter in which the distance between end rungs of adjacent ladder elements is collapsed, and a variable second diameter in which the distance between end rungs of adjacent ladder elements is expanded.
An aggregated dataset of serially collected influenza A virus morbidity and titer measurements from virus-infected ferrets.

Data from influenza A virus (IAV) infected ferrets (Mustela putorius furo) provides invaluable information towards the study of novel and emerging viruses that pose a threat to human health. This gold standard animal model can recapitulate many clinical signs of infection present in IAV-infected humans, support virus replication of human and zoonotic strains without prior adaptation, and permit evaluation of virus transmissibility by multiple modes. While ferrets have been employed in risk assessment settings for >20 years, results from this work are typically reported in discrete stand-alone publications, making aggregation of raw data from this work over time nearly impossible. Here, we describe a dataset of 728 ferrets inoculated with 126 unique IAV, conducted by a single research group (NCIRD/ID/IPB/Pathogenesis Laboratory Team) under a uniform experimental protocol. This collection of morbidity, mortality, and viral titer data represents the largest publicly available dataset to date of in vivo-generated IAV infection outcomes on a per-individual ferret level.

Published Data Descriptor for more information:
Kieran TJ, Sun X, Creager HM, Tumpey TM, Maine TR, Belser JA. 2024. An aggregated dataset of serial morbidity and titer measurements from influenza A virus-infected ferrets. Sci Data 11, 510. https://doi.org/10.1038/s41597-024-03256-6

Additional publications using and describing data:
Kieran TJ, Sun X, Maines TR, Beauchemin CAA, Belser JA. 2024. Exploring associations between viral titer measurements and disease outcomes in ferrets inoculated with 125 contemporary influenza A viruses. J Virol98:e01661-23.https://doi.org/10.1128/jvi.01661-23

Belser JA, Kieran TJ, Mitchell ZA, Sun X, Mayfield K, Tumpey TM, Spengler JR, Maines TR. 2024. Key considerations to improve the normalization, interpretation and reproducibility of morbidity data in mammalian models of viral disease. Dis Model Mech; 17 (3): dmm050511. doi: https://doi.org/10.1242/dmm.050511

Kieran TJ, Sun X, Maines TR, Belser JA. 2024. Machine learning approaches for influenza A virus risk assessment identifies predictive correlates using ferret model in vivo data. Communications Biology 7, 927. https://doi.org/10.1038/s42003-024-06629-0
Compound 527669: Butanoic acid, 1-methyl-3-butenyl ester

Chemical compound data from PubChem database. IUPAC Name: pent-4-en-2-yl butanoate. Molecular Formula: C9H16O2. Molecular Weight: 156.22. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401106-T1: [Translated] BALLOON CATHETER

The balloon catheter comprises a proximal shaft (10) and a distal shaft (12). A transition section (15) is located therebetween, in which a guidewire lumen (17) projects laterally. In order to enhance the resistance to buckling and the rigidity, the transition section (15) contains a wire filament (20) consisting of windings placed against one another. A stiffening wire (25) extends through the wire filament (20), said wire extending onto the adjacent shafts (10,12).
Patent AT-E400789-T1: [Translated] HEAT EXCHANGER OF A VENTILATION SYSTEM

A heat exchanger of a ventilating system includes: heat exchange plates having first air passage through which indoor air being discharged to outside of a building passes and a second air passage through which outdoor air being introduced to the interior of the building passes which are sequentially formed: first corrugation plates attached to the first air passage; and second corrugation plates attached to the second air passage, wherein the heat exchange plates are made of a paper material with numerous fine holes that are able to generate a capillary phenomenon and loess which radiates far infrared ray. Heat exchange and moisture exchange between the indoor air and the outdoor air are performed simultaneously, and a cleaning function of removing a harmful material contained in outdoor air can be carried out.
Drug overdose death rates, by drug type, sex, age, race, and Hispanic origin: United States

Data on drug overdose death rates, by drug type and selected population characteristics. Please refer to the PDF or Excel version of this table in the HUS 2019 Data Finder (https://www.cdc.gov/nchs/hus/contents2019.htm) for critical information about measures, definitions, and changes over time. 

SOURCE: NCHS, National Vital Statistics System, numerator data from annual public-use Mortality Files; denominator data from U.S. Census Bureau national population estimates; and Murphy SL, Xu JQ, Kochanek KD, Arias E, Tejada-Vera B. Deaths: Final data for 2018. National Vital Statistics Reports; vol 69 no 13. Hyattsville, MD: National Center for Health Statistics.2021. Available from: https://www.cdc.gov/nchs/products/nvsr.htm. For more information on the National Vital Statistics System, see the corresponding Appendix entry at https://www.cdc.gov/nchs/data/hus/hus19-appendix-508.pdf.
Compound 525877: N,N-Dimethyl-N'-(3-methoxyphenyl)-pivalamidine

Chemical compound data from PubChem database. IUPAC Name: N'-(3-methoxyphenyl)-N,N,2,2-tetramethylpropanimidamide. Molecular Formula: C14H22N2O. Molecular Weight: 234.34. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
South: 2011-2012 NSDUH

This report presents the South\'s (e.g., combines Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia) estimates for 25 measures of substance use and mental health based on the combined 2011 and 2012 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided for the South for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
2017 NSDUH Detailed Tables

Results from the 2017 National Survey on Drug Use and Health: Detailed Tables is a collection of tables presenting national estimates from the National Survey on Drug Use and Health (NSDUH). These tables present information for youths aged 12 to 17 and adults aged 18 or older (separately and combined) on drug, alcohol, and tobacco use, as well as substance use disorder (SUD), risk and availability of substance use, treatment, health topics, and alcohol consumption. For youths, additional topics include youth experiences and measures on mental health service utilization, major depressive episode (MDE), and treatment for depression (among youths with MDE). For adults, additional topics include measures on any mental illness (AMI), serious mental illness (SMI), AMI excluding SMI, mental health service utilization (i.e., treatment or counseling for mental health issues), suicidal thoughts and behaviors, MDE, treatment for depression (among adults with MDE), and serious psychological distress (SPD). Measures such as the co-occurrence of mental disorders with substance use or with SUDs also are presented for both adults and youths. Measures of these behaviors and characteristics are presented by a variety of demographic, geographic, and other variables. The estimates in the tables include prevalence rates of the behaviors, numbers of persons engaging in these behaviors, and other measures.
Patent AT-E400257-T1: [Translated] STABLE PHARMACEUTICAL COMPOSITION CONTAINING LINEZOLID FORM IV

A method of formulating linezolid to provide a solid pharmaceutical composition comprising linezolid Form IV substantially free of linezolid Form II, methods of treating a condition responsive to linezolid in a patient comprising administering to the patient a solid pharmaceutical composition comprising linezolid form IV substantially free of linezolid Form II.
Compound 526515: 6-Isothiocyanato-hexanoic acid ethyl ester

Chemical compound data from PubChem database. IUPAC Name: ethyl 6-isothiocyanatohexanoate. Molecular Formula: C9H15NO2S. Molecular Weight: 201.29. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526261: 1,3,4,6,7,8-Hexabromo-dibenzofuran

Chemical compound data from PubChem database. IUPAC Name: 1,3,4,6,7,8-hexabromodibenzofuran. Molecular Formula: C12H2Br6O. Molecular Weight: 641.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Weekly Cumulative COVID-19 Vaccination Coverage and Intent, Overall, by Selected Demographics and Jurisdiction, Among Adults 18 Years and Older

Weekly COVID-19 Vaccination Coverage and intent among adults 18 Years and Older by Demographic Characteristics and Jurisdiction • Weekly estimates of COVID-19 vaccination coverage and intent among adults 18 years and older are calculated using data from the National Immunization Survey–Adult COVID Module (NIS–ACM) (https://www.cdc.gov/nis/about/). 

Weekly comparisons to previous season should take into account differences between seasons in vaccine availability dates. 2023–24 COVID-19 vaccines were first available mid-September 2023, and 2024–25 COVID-19 vaccines were first available at the end of August 2024.
Compound 526109: 13,17-Dimethylheptatriacontane

Chemical compound data from PubChem database. IUPAC Name: 13,17-dimethylheptatriacontane. Molecular Formula: C39H80. Molecular Weight: 549.1. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Child Welfare Outcomes Report Data Site

The Child Welfare Outcomes Report data site
  
  

 presents the most current publicly available data from the annual Child Welfare Outcomes Report. This includes data on state performance on seven child welfare outcomes measures as well as data not currently available in the full Report, including additional context data, characteristics of child maltreatment victims, characteristics of children in foster care, and alternate categorical breakdowns for all race/ethnicity data. The site allows users to create customized outputs and compare data across time and states.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 528700: 2-Cyclopenten-1-one, 2-hydroxy-4,4-dimethyl

Chemical compound data from PubChem database. IUPAC Name: 2-hydroxy-4,4-dimethylcyclopent-2-en-1-one. Molecular Formula: C7H10O2. Molecular Weight: 126.15. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2010 CMHS Uniform Reporting System (URS) Output Tables for Nebraska

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2010. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Calcium gluconate

Calcium Gluconate is an intravenous prescription medication used to treat low calcium levels in the blood, support blood clotting, and bind phosphates. Manufactured by Amneal Pharmaceuticals, it comes in solution form with strengths like 1g/10mL, 5g/50mL, or 10g/100mL, all providing 100mg/mL of calcium gluconate. This information was generated using AI and is provided for informational and research purposes only.
Nevada: 2011-2012 NSDUH

This report presents Nevada\'s estimates for 25 measures of substance use and mental health based on the combined 2011 and 2012 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided by State and for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Census Data - Languages spoken in Chicago, 2008 – 2012

This dataset contains estimates of the number of residents aged 5 years or older in Chicago who “speak English less than very well,” by the non-English language spoken at home and community area of residence, for the years 2008 – 2012.  See the full dataset description for more information at: https://data.cityofchicago.org/api/views/fpup-mc9v/files/dK6ZKRQZJ7XEugvUavf5MNrGNW11AjdWw0vkpj9EGjg?download=true&filename=P:\EPI\OEPHI\MATERIALS\REFERENCES\ECONOMIC_INDICATORS\Dataset_Description_Languages_2012_FOR_PORTAL_ONLY.pdf
Microscopy of bacterial translocation during small bowel obstruction and ischemia in vivo – a new animal model

Background
          Existing animal models provide only indirect information about the pathogenesis of infections caused by indigenous gastrointestinal microflora and the kinetics of bacterial translocation. The aim of this study was to develop a novel animal model to assess bacterial translocation and intestinal barrier function in vivo.
        
        
          Methods
          In anaesthetized male Wistar rats, 0.5 ml of a suspension of green fluorescent protein-transfected E. coli was administered by intraluminal injection in a model of small bowel obstruction. Animals were randomly subjected to non-ischemic or ischemic bowel obstruction. Ischemia was induced by selective clamping of the terminal mesenteric vessels feeding the obstructed bowel loop. Time intervals necessary for translocation of E. coli into the submucosal stroma and the muscularis propria was assessed using intravital microscopy.
        
        
          Results
          Bacterial translocation into the submucosa and muscularis propria took a mean of 36 ± 8 min and 80 ± 10 min, respectively, in small bowel obstruction. Intestinal ischemia significantly accelerated bacterial translocation into the submucosa (11 ± 5 min, p < 0.0001) and muscularis (66 ± 7 min; p = 0.004). Green fluorescent protein-transfected E. coli were visible in frozen sections of small bowel, mesentery, liver and spleen taken two hours after E. coli administration.
        
        
          Conclusions
          Intravital microscopy of fluorescent bacteria is a novel approach to study bacterial translocation in vivo. We have applied this technique to define minimal bacterial transit time as a functional parameter of intestinal barrier function.